Cargando…
System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019
OBJECTIVE: To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access. METHODS: We conducted a population-based retrospective study of all individuals...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793576/ https://www.ncbi.nlm.nih.gov/pubmed/36572934 http://dx.doi.org/10.1186/s41927-022-00315-6 |
_version_ | 1784859871224528896 |
---|---|
author | Barber, Claire E. H. Lacaille, Diane Croxford, Ruth Barnabe, Cheryl Marshall, Deborah A. Abrahamowicz, Michal Xie, Hui Avina-Zubieta, J. Antonio Esdaile, John M. Hazlewood, Glen Faris, Peter Katz, Steven MacMullan, Paul Mosher, Dianne Widdifield, Jessica |
author_facet | Barber, Claire E. H. Lacaille, Diane Croxford, Ruth Barnabe, Cheryl Marshall, Deborah A. Abrahamowicz, Michal Xie, Hui Avina-Zubieta, J. Antonio Esdaile, John M. Hazlewood, Glen Faris, Peter Katz, Steven MacMullan, Paul Mosher, Dianne Widdifield, Jessica |
author_sort | Barber, Claire E. H. |
collection | PubMed |
description | OBJECTIVE: To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access. METHODS: We conducted a population-based retrospective study of all individuals diagnosed with RA between January 1, 2002 and December 31, 2019. Performance measures evaluated were: (i) percentage of RA patients seen by a rheumatologist within one year of diagnosis; and (ii) percentage of individuals with RA aged 66 years and older (whose prescription drugs are publicly funded) dispensed a disease modifying anti-rheumatic drug (DMARD) within 30 days after initial rheumatologist visit. Logistic regression was used to assess whether performance improved over time and whether the improvements differed by rheumatology supply, dichotomized as < 1 rheumatologist per 75,000 adults versus ≥1 per 75,000. RESULTS: Among 112,494 incident RA patients, 84% saw a rheumatologist within one year: The percentage increased over time (adjusted odds ratio (OR) 2019 vs. 2002 = 1.43, p < 0.0001) and was consistently higher in regions with higher rheumatologist supply (OR = 1.73, 95% CI 1.67–1.80). Among seniors who were seen by a rheumatologist within 1 year of their diagnosis the likelihood of timely DMARD treatment was lower among individuals residing in regions with higher rheumatologist supply (OR = 0.90 95% CI 0.83–0.97). These trends persisted after adjusting for other covariates. CONCLUSION: While access to rheumatologists and treatment improved over time, shortcomings remain, particularly for DMARD use. Patients residing in regions with higher rheumatology supply were more likely to access care but less likely to receive timely treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00315-6. |
format | Online Article Text |
id | pubmed-9793576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97935762022-12-28 System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 Barber, Claire E. H. Lacaille, Diane Croxford, Ruth Barnabe, Cheryl Marshall, Deborah A. Abrahamowicz, Michal Xie, Hui Avina-Zubieta, J. Antonio Esdaile, John M. Hazlewood, Glen Faris, Peter Katz, Steven MacMullan, Paul Mosher, Dianne Widdifield, Jessica BMC Rheumatol Research OBJECTIVE: To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access. METHODS: We conducted a population-based retrospective study of all individuals diagnosed with RA between January 1, 2002 and December 31, 2019. Performance measures evaluated were: (i) percentage of RA patients seen by a rheumatologist within one year of diagnosis; and (ii) percentage of individuals with RA aged 66 years and older (whose prescription drugs are publicly funded) dispensed a disease modifying anti-rheumatic drug (DMARD) within 30 days after initial rheumatologist visit. Logistic regression was used to assess whether performance improved over time and whether the improvements differed by rheumatology supply, dichotomized as < 1 rheumatologist per 75,000 adults versus ≥1 per 75,000. RESULTS: Among 112,494 incident RA patients, 84% saw a rheumatologist within one year: The percentage increased over time (adjusted odds ratio (OR) 2019 vs. 2002 = 1.43, p < 0.0001) and was consistently higher in regions with higher rheumatologist supply (OR = 1.73, 95% CI 1.67–1.80). Among seniors who were seen by a rheumatologist within 1 year of their diagnosis the likelihood of timely DMARD treatment was lower among individuals residing in regions with higher rheumatologist supply (OR = 0.90 95% CI 0.83–0.97). These trends persisted after adjusting for other covariates. CONCLUSION: While access to rheumatologists and treatment improved over time, shortcomings remain, particularly for DMARD use. Patients residing in regions with higher rheumatology supply were more likely to access care but less likely to receive timely treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00315-6. BioMed Central 2022-12-27 /pmc/articles/PMC9793576/ /pubmed/36572934 http://dx.doi.org/10.1186/s41927-022-00315-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Barber, Claire E. H. Lacaille, Diane Croxford, Ruth Barnabe, Cheryl Marshall, Deborah A. Abrahamowicz, Michal Xie, Hui Avina-Zubieta, J. Antonio Esdaile, John M. Hazlewood, Glen Faris, Peter Katz, Steven MacMullan, Paul Mosher, Dianne Widdifield, Jessica System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 |
title | System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 |
title_full | System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 |
title_fullStr | System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 |
title_full_unstemmed | System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 |
title_short | System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 |
title_sort | system-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in ontario, canada, 2002–2019 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793576/ https://www.ncbi.nlm.nih.gov/pubmed/36572934 http://dx.doi.org/10.1186/s41927-022-00315-6 |
work_keys_str_mv | AT barberclaireeh systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT lacaillediane systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT croxfordruth systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT barnabecheryl systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT marshalldeboraha systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT abrahamowiczmichal systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT xiehui systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT avinazubietajantonio systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT esdailejohnm systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT hazlewoodglen systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT farispeter systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT katzsteven systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT macmullanpaul systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT mosherdianne systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 AT widdifieldjessica systemlevelperformancemeasuresofaccesstorheumatologycareapopulationbasedretrospectivestudyoftrendsovertimeandtheimpactofregionalrheumatologistsupplyinontariocanada20022019 |